Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.

13-Dec-2001
KIRKLAND, Wash., December 11, 2001 - Rosetta Biosoftware today announced that Aventis Pharmaceuticals, Inc., the U.S. business of Frankfurt, Germany-based Aventis Pharma AG, has licensed the Rosetta Resolver Gene Expression Data Analysis System. The Rosetta Resolver system is an enterprise bioinformatics solution for gene expression research developed by Rosetta Biosoftware and distributed by Rosetta and Agilent Technologies, Inc.. The Rosetta Resolver system can be used with a variety of third party and internally developed DNA microarray technologies, including Agilent DNA microarrays. Dr. Christoph Brockel, head of Aventis Pharma's Informatics group in Cambridge, Massachusetts, and leader of Aventis' gene expression Informatics project, said, "We selected the Rosetta Resolver system because of its high performance, multidimensional analysis capabilities and customizability. In addition, the Rosetta Resolver system's ability to be networked into a multi-server global solution for our distributed enterprise was important to us." About the Rosetta Resolver System The Rosetta Resolver system provides high-capacity data storage, retrieval and analysis of gene Expression data. The system is ideal for Life Science research organizations that need to assess compound specificity or toxicity, identify new genes or therapeutic targets, or compare and analyze large databases of expression profiles. The Rosetta Resolver system combines flexibility and ease of use with high-performance algorithms to produce an enterprise solution for rapid analysis of gene expression data. The system can accept and analyze data from a wide variety of expression profiling formats, including Agilent DNA microarrays, and applies Rosetta Biosoftware's proprietary error models to yield quality statistics for every gene expression measurement. These statistics are automatically leveraged by all analysis tools, ensuring reliable results. Life science organizations that have licensed the Rosetta Resolver system include many of the top drug development companies in the world, such as Biogen, Bristol-Myers Squibb, GlaxoSmithKline and Merck & Co., Inc., and premier academic institutions such as the Harvard University Center for genomics Research.

Other news from the department science

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?